SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-15-000042
Filing Date
2015-11-06
Accepted
2015-11-06 11:16:47
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q033115.htm 10-Q 995193
2 ex12.htm EX-12 62273
3 exhibit31_1.htm EX-31 12938
4 exhibit31_2.htm EX-31 12920
5 exhibit32_1.htm EX-32 3373
6 exhibit32_2.htm EX-32 3306
7 AMENDMENT TO CREDIT AGREEMENT exhibit10_1.htm EX-10.1 107955
8 BIOTHRAX CDC MOD exhibit10_2.htm EX-10.2 54163
  Complete submission text file 0001367644-15-000042.txt   4546494

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ebs-20150930.xml EX-101.INS 813148
10 XBRL TAXONOMY EXTENSION SCHEMA ebs-20150930.xsd EX-101.SCH 30703
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20150930_cal.xml EX-101.CAL 58822
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20150930_def.xml EX-101.DEF 130673
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20150930_lab.xml EX-101.LAB 455337
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20150930_pre.xml EX-101.PRE 264248
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 151203132
SIC: 2834 Pharmaceutical Preparations